CNTA CENTESSA PHARMACEUTICALS PLC Capital Structure Changes 8-K Filing 2024 - Capital Raise Centessa Pharmaceuticals plc has entered into an underwriting agreement to sell 15,254,237 American Depositary Shares at $14.75 each, aiming to raise approximately $211 million for product development and corporate purposes.Get access to all SEC 8-K filings of the CENTESSA PHARMACEUTICALS PLC